Structure-Function That Matters Clinically

Prev
 1 / 20 
Next
Prev
 1 / 20 
Next

Learning objectives

After completing this quiz, the learner should be able to:

  • recognize VWF as a force-responsive multimeric system rather than a simple plasma level
  • interpret discordance between VWF antigen, activity, multimers, and factor VIII
  • distinguish quantitative VWF deficiency from qualitative structure-function defects
  • explain how shear both activates VWF and exposes it to ADAMTS13 cleavage
  • identify how specific VWF domains map to clinical VWD phenotypes
  • apply structure-function reasoning to subtype classification and treatment choices
  • avoid common diagnostic pitfalls involving ristocetin-based assays, type 2N VWD, and desmopressin response

What is the central thesis of the essay?

a
VWF levels alone determine bleeding risk in VWD
Incorrect because the essay emphasizes that VWF level alone is insufficient to predict phenotype.
b
VWF is primarily a carrier protein for factor VIII
Incorrect because factor VIII carriage is one important VWF function, but not the central thesis.
c
VWF is a force-responsive multimeric adhesive system
C is correct because the essay frames VWF as a mechanically responsive multimeric protein whose structure, size, domain architecture, and force-dependent conformational changes determine clinical behavior. This concept explains why VWD cannot be reduced to “low VWF” and why phenotype, labs, and treatment must be interpreted structurally.
d
VWF classification is determined mainly by genotype
Incorrect because genotype can support classification but does not replace protein phenotype or clinical reasoning.

A patient has VWF antigen of 58 IU/dL, markedly reduced platelet-dependent VWF activity, and normal multimer distribution. Which structure-function problem is most likely?

a
Impaired A1-GPIbα interaction
A is correct because reduced platelet-dependent activity with preserved antigen and normal multimers suggests a qualitative platelet-binding defect. This pattern resembles type 2M VWD, in which VWF is present and multimer distribution may be preserved, but A1-mediated interaction with platelet GPIbα is impaired.
b
Complete absence of VWF synthesis
Complete absence of synthesis would suggest type 3 VWD with absent or near-absent VWF
c
Defective factor VIII binding by D′D3
Defective factor VIII binding would produce a type 2N-like pattern with disproportionately low factor VIII.
d
Accelerated clearance of mature VWF
Accelerated clearance usually lowers steady-state VWF levels and may produce a short-lived desmopressin response.

Why are high-molecular-weight VWF multimers disproportionately important for hemostasis?

a
They are resistant to all proteolytic cleavage
Large multimers are regulated by ADAMTS13 cleavage.
b
They contain more adhesive binding sites and respond more strongly to shear
B is correct because high-molecular-weight multimers provide multiple binding sites for platelets and collagen and are especially effective under shear. The reasoning principle is multimer size is function: larger multimers are not simply bigger, they are mechanically and adhesively more effective.
c
They bind factor VIII more strongly than smaller multimers
The essay does not frame factor VIII binding as primarily dependent on multimer size.
d
They are produced only by platelets
High-molecular-weight multimers are stored in endothelial Weibel-Palade bodies as well as platelet α-granules.

Which statement best captures the essay’s “shear is both activator and editor” concept?

a
Shear activates platelets but has little direct effect on VWF
The essay emphasizes direct force-dependent conformational change in VWF.
b
Shear prevents VWF from interacting with collagen
Collagen binding localizes VWF to injured matrix.
c
Shear affects acquired VWF disorders but not inherited VWD
Shear-dependent biology explains both inherited qualitative variants and acquired high-shear VWF loss.
d
Shear exposes VWF platelet-binding function and also exposes VWF to ADAMTS13 cleavage
Shear elongates VWF and makes platelet-binding regions functionally available, while also unfolding A2 enough to expose the ADAMTS13 cleavage site. The reasoning principle is mechanical gating: the same force that activates VWF for hemostasis also enables control of VWF size.

A clinician considers desmopressin for a patient with VWD. Which point best reflects the essay’s structure-function logic?

a
Desmopressin is appropriate whenever VWF antigen is below the normal range
VWF antigen level alone does not determine desmopressin suitability.
b
Desmopressin response should be judged only by the peak VWF level
A brisk but short-lived response may be inadequate for prolonged bleeding-risk windows.
c
Desmopressin tests endogenous VWF storage, release, and survival
C is correct because desmopressin releases endogenous VWF from endothelial stores, so its usefulness depends on whether the patient has stored, functional VWF and whether the released VWF persists long enough. The essay emphasizes that both peak and duration matter, especially in clearance phenotypes.
d
Desmopressin is preferred in type 3 VWD
Type 3 VWD has absent or near-absent VWF and generally requires replacement.

Why can type 2B VWD cause bleeding despite increased VWF-platelet binding?

a
Increased A1-GPIbα binding can promote VWF-platelet complex clearance and loss of high-molecular-weight multimers
A is correct because type 2B is a gain-of-function platelet-binding disorder. VWF binds platelet GPIbα too readily, which can lead to clearance of VWF-platelet complexes, loss of high-molecular-weight multimers, and sometimes thrombocytopenia. The key reasoning principle is that too much platelet binding can cause bleeding, not only thrombosis.
b
Increased binding prevents factor VIII from binding VWF
The primary problem in type 2B is abnormal platelet binding, not defective factor VIII carriage.
c
Increased binding causes complete absence of VWF synthesis
Complete absence of VWF synthesis suggests type 3 VWD.
d
Increased binding makes VWF resistant to ADAMTS13
The essay links type 2B to platelet binding and clearance, not ADAMTS13 resistance.

A woman has low factor VIII, normal or mildly reduced VWF antigen, and a family pattern that does not fit X-linked hemophilia A. Which VWD subtype should be considered?

a
Type 2A
Type 2A is primarily associated with loss of high-molecular-weight multimers.
b
Type 2B
Type 2B involves increased A1-GPIbα binding and may cause thrombocytopenia.
c
Type 2M
Type 2M involves impaired platelet or collagen binding with relatively preserved multimers.
d
Type 2N
D is correct because type 2N VWD is a carrier-function defect in which the D′D3 region cannot adequately bind and protect factor VIII. It can mimic mild hemophilia A because factor VIII is disproportionately low compared with VWF antigen.

A patient with severe aortic stenosis develops gastrointestinal bleeding and has loss of high-molecular-weight VWF multimers. What is the best structure-function explanation?

a
Reduced endothelial synthesis of VWF due to VWF gene mutation
Aortic stenosis causes an acquired mechanical problem, not inherited VWF underproduction.
b
High shear promotes excessive VWF unfolding and proteolysis
B is correct because high-shear cardiovascular states can cause acquired VWF dysfunction by excessive unfolding and proteolysis, selectively depleting high-molecular-weight multimers. This produces an acquired type 2A-like pattern and is a mechanism underlying Heyde syndrome.
c
Defective D′D3-mediated factor VIII binding
The key abnormality is loss of large multimers, not isolated factor VIII carriage failure.
d
Platelet-type VWD caused by abnormal GPIbα
Platelet-type VWD is a congenital platelet receptor problem, not a high-shear acquired syndrome.

Which laboratory pattern most strongly suggests a qualitative VWF defect rather than a simple quantitative deficiency?

a
VWF antigen and activity are proportionately reduced
Proportionate reduction supports a quantitative pattern such as type 1 VWD.
b
VWF activity is disproportionately reduced compared with antigen
B is correct because discordance between VWF activity and antigen suggests that VWF protein is present but not functioning normally. This is the core reasoning behind using activity-to-antigen relationships to identify qualitative type 2 patterns.
c
VWF antigen is absent and factor VIII is markedly low
Absent VWF with low factor VIII suggests type 3 VWD.
d
VWF antigen rises after desmopressin
A rise after desmopressin indicates release of endogenous VWF, not necessarily a qualitative defect.

Which statement best captures the essay’s approach to treatment planning in borderland VWD?

a
Perfect diagnostic classification must precede any procedure plan
A provisional plan may be appropriate even while the long-term diagnosis remains under evaluation.
b
If the label is uncertain, no treatment plan is appropriate
Uncertainty should prompt careful planning, not inaction.
c
Safety often depends more on preparation than on perfect classification
The essay argues that the practical question is often: what situations require a plan? Procedure type, bleeding history, treatment response, and patient goals may matter more than label purity.
d
Borderline patients never need hematology input
Borderland patients may need hematology input for surgery, childbirth, dental extraction, or other challenges.

What is the major pitfall of interpreting VWF activity assays as if they directly measure in vivo VWF function?

a
Activity assays measure factor VIII concentration directly
VWF activity assays assess VWF function, not factor VIII concentration directly.
b
Static assays may not reproduce physiologic shear-dependent VWF behavior
B is correct because VWF function in vivo depends on flow, shear, multimer size, and conformational change. Static assays, especially ristocetin-based assays, provide constrained readouts and may be affected by assay-specific artifacts.
c
Activity assays are unaffected by A1 polymorphisms
A1 polymorphisms such as D1472H can affect ristocetin-dependent assays.
d
Activity assays always distinguish type 2A from type 2B
Subtype classification may require integration of activity, antigen, multimers, platelet count, RIPA, collagen binding, factor VIII, and sometimes genetics.

Which phrase best summarizes the central ethical lesson of the essay?

a
Thresholds eliminate uncertainty
Thresholds organize uncertainty; they do not eliminate it.
b
The line between normal variation and disease is where thinking ends
The essay says the opposite: the line is where careful interpretation begins.
c
Thresholds are tools for decision-making, not measures of human worth or suffering
The essay argues that thresholds are necessary but ethically consequential. They guide care, but they should not define the person or invalidate experience.
d
Borderline values should always be ignored
Borderline values require context, not dismissal.

Force-gated VWF biology

D′D3 binds and stabilizes factor VIII
Normal antigen does not exclude qualitative VWF dysfunction
A3 binds collagen I/III at sites of vascular injury
A2 unfolds to expose the ADAMTS13 cleavage site
Ristocetin-based assays do not reproduce physiologic shear
Type 2B may worsen with desmopressin because released abnormal VWF can bind platelets too readily
CK domain supports C-terminal dimerization
High-molecular-weight multimers dominate platelet adhesion under flow
A1 becomes competent to bind platelet GPIbα under shear
Excess shear in aortic stenosis can cause acquired loss of large multimers
D1472H can reduce ristocetin-dependent activity without necessarily causing bleeding
VWFpp helps facilitate multimerization and regulated storage
A good desmopressin peak may be misleading if VWF clears rapidly
Similar VWF antigen levels can have different bleeding risk if multimer distribution differs
Type 2N can be mistaken for mild hemophilia A
Supports concern
Constitutive or baseline VWF functions
Clinical interpretation pitfalls

Match each concept with the best description.

A2 shear bolt
VWF activity-to-antigen discordance
Type 2N VWD
A clue that VWF protein is present but one of its functions is disproportionately impaired
A carrier-function defect in which VWF fails to adequately bind and protect factor VIII.
A force-gated regulatory module that exposes the ADAMTS13 cleavage site when VWF unfolds
Correct! Sorry, Incorrect.

Closing Note

VWF is not a number floating in plasma. It is a molecule designed for hemostasis in moving blood.

Its structure determines when it stays quiet, when it binds platelets, when it anchors to collagen, when it protects factor VIII, and when it is edited by ADAMTS13. The same architecture that permits normal hemostasis also explains why VWD can appear as low antigen, low activity, missing multimers, low factor VIII, excessive platelet binding, or rapid clearance.

The major danger is numerical thinking without structural interpretation. A VWF antigen level, activity result, multimer pattern, or desmopressin peak is only a window into the system. It is not the system itself.

The clinical question is not simply, “Is the VWF low?”

The better question is, “Which part of the VWF system is failing, and what does that failure predict?”

Prev
 1 / 20 
Next